The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
News|Slideshows|September 16, 2016
A Mysterious Case of Tummy Pimples
Author(s)Jonathan A. Schneider, DO
A few days after a homecoming party a 17-year-old girl presents with a pruritic rash at her waist and on her upper arms. What went on?
Advertisement
The slides above provide a close look at the itchy eruption on a teenage girl's trunk. Is this something you have seen before? What's your diagnosis?
Advertisement
Related to this article
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
Advertisement
Advertisement
Trending on Patient Care Online
1
Beyond Semaglutide and Tirzepatide: The Next Wave of Obesity Medicines
2
FDA Grants Priority Review to Elinzanetant for VMS in HR+ Breast Cancer Patients on Endocrine Therapy
3
FDA Expands Baricitinib Approval to Adolescents With Severe Alopecia Areata
4
Detecting Atrial Fibrillation in Primary Care: Warning Signs and Modifiable Risk Factors
5